A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of ...

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...

Big Brother season 27 star Mickey Lee was hospitalized after a "series of cardiac arrests," according to a GoFundMe page set ...

THE HSE have issued an urgent Christmas alert over a “life-threatening condition” that impacts 1 in 4 – here’s the warning ...

Investing.com -- A patient died after receiving Pfizer Inc.’s (NYSE:PFE) hemophilia drug Hympavzi, adding to challenges for the company in blood disorder treatments.

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.

Lenovo is one of the brands still making a considerable number of Android tablets each year, and we've been spending some time with the latest Yoga Tab ...

Professor Kim Jae-hoon (54) of neurosurgery will be inaugurated as the 20th hospital director of Nowon Eulji University ...

Last month, in a 6 to 1 decision, New Jersey’s highest court banned testimony on Shaken Baby Syndrome (SBS) from the state’s ...